GlobeNewswire Inc.··NaIntegra LifeSciences Raises EPS Outlook After Q1 Beat, Names New CEO
Integra LifeSciences reported Q1 2026 revenues of $391.9M with improved margins, raising full-year EPS guidance while appointing Stuart Essig as new President and CEO.
IARTrevenue growthleadership transition